Noriko Uchiyama

1.3k citations

28 papers · 769 indexed · h-index 14

Molecular Biology
Organic Chemistry top 10%
Oncology
Computational Theory and Mathematics top 5%
Pharmacology top 10%

Co-authors: Tomohiro Kawamoto Morihisa Saitoh Eiji Kimura Jun Kunitomo Hiroki Iwashita Masakuni Kori Yumiko Uno Douglas R. Dougan
Topics: Wnt/β-catenin signaling in development and cancer (4 papers)Microtubule and mitosis dynamics (3 papers)Cancer-related Molecular Pathways (3 papers)
Cited by: Molecular Biology Organic Chemistry Computational Theory and Mathematics
Journals: The Journal of Experimental Medicine Brain Research Biochemical and Biophysical Research Communications
Partner nations: Japan United States Canada

In The Last Decade

Noriko Uchiyama

27 papers receiving 754 citations

Peers

Countries citing papers authored by Noriko Uchiyama

Since Specialization

Citations

This map shows the geographic impact of Noriko Uchiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Uchiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Uchiyama more than expected).

Fields of papers citing papers by Noriko Uchiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Uchiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Uchiyama. The network helps show where Noriko Uchiyama may publish in the future.

Co-authorship network of co-authors of Noriko Uchiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Uchiyama. A scholar is included among the top collaborators of Noriko Uchiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Uchiyama. Noriko Uchiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Rogocekib (CTX-712): A Potent and Selective CLK Inhibitor for Cancer Treatment 2025 ·ACS Medicinal Chemistry Letters ·Youichi Kawakita,(unknown),(unknown),Y. ITO,(unknown),Hiroshi Banno,Xin Liu,Koji Ono,(unknown),(unknown),Kenichi Iwai,Yukiko Yamamoto,Misa Iwatani,Noriko Uchiyama,(unknown),Akio Mizutani,Yoshihiko Satoh,Yasuyoshi Arikawa,Daisuke Morishita,Kenichiro Shimokawa	0
2	Discovery of a Novel and Brain-Penetrant O -GlcNAcase Inhibitor via Virtual Screening, Structure-Based Analysis, and Rational Lead Optimization 2021 ·Journal of Medicinal Chemistry ·Michiko Tawada,Makoto Fushimi,(unknown),(unknown),Noriko Uchiyama,Yohei Kosugi,Weston Lane,Richard Tjhen,Satoshi Endo,Tatsuki Koike	10
3	Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent 2020 ·Journal of Medicinal Chemistry ·Osamu Kurasawa,T. Miyazaki,Misaki Homma,Yuya Oguro,Takashi Imada,Noriko Uchiyama,Kenichi Iwai,Yukiko Yamamoto,Momoko Ohori,(unknown),Hiroshi Sugimoto,Kentaro Iwata,R.J. Skene,Isaac Hoffman,Akihiro Ohashi,Toshiyuki Nomura,Nobuo Cho	16
4	New phenotypic cytotoxicity assay for ROS-inducing compounds using rat renal epithelial cells 2020 ·Toxicology Letters ·Noriko Uchiyama,Tomoya Yukawa,Yvonne P. Dragan,Matthew P. Wagoner,Russell Naven	1
5	Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase 2020 ·Journal of Medicinal Chemistry ·Yuta Tanaka,Osamu Kurasawa,(unknown),Michael G. Klein,Koji Ono,Bunnai Saito,Shigemitsu Matsumoto,Masanori Okaniwa,(unknown),Daisuke Morishita,Satoshi Kitazawa,Noriko Uchiyama,Kazumasa Ogawa,Hiromichi Kimura,Shinichi Imamura	19
6	Discovery of 3-Benzyl-1-(trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors 2018 ·Journal of Medicinal Chemistry ·Masahiro Ito,Toshio Tanaka,(unknown),Noriko Uchiyama,Hironori Kokubo,(unknown),Michael G. Klein,Hua Zou,(unknown),Mitsuyo Kondo,Tomoya Sameshima,Shinsuke Araki,Satoshi Endo,Tomohiro Kawamoto,Gregg B. Morin,Samuel Aparício,Atsushi Nakanishi,Hironobu Maezaki,Yasuhiro Imaeda	51
7	Identification of AHCY inhibitors using novel high-throughput mass spectrometry 2017 ·Biochemical and Biophysical Research Communications ·Noriko Uchiyama,Douglas R. Dougan,J. David Lawson,H. Kimura,Shin-ichi Matsumoto,(unknown),Tomohiro Kawamoto	9
8	Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders 2017 ·Journal of Medicinal Chemistry ·Satoshi Mikami,Shinji Nakamura,(unknown),Izumi Nomura,Masanori Kawasaki,Shigekazu Sasaki,Hideyuki Oki,Hironori Kokubo,Isaac Hoffman,Hua Zou,Noriko Uchiyama,Kosuke Nakashima,(unknown),Haruka Imada,Noriko Suzuki,Hiroki Iwashita,Takahiko Taniguchi	26
9	Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a 2017 ·European Journal of Pharmacology ·Noriko Uchiyama,(unknown),Tomohiro Kawamoto	16
10	2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase 2017 ·Bioorganic & Medicinal Chemistry ·Osamu Kurasawa,Misaki Homma,Yuya Oguro,T. Miyazaki,Kouji Mori,Noriko Uchiyama,Kenichi Iwai,Akihiro Ohashi,(unknown),Sei Yoshida,Nobuo Cho	10
11	Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Andre A. Kiryanov,(unknown),(unknown),Christopher M. McBride,Victoria A. Feher,(unknown),Yan Liu,(unknown),Noriko Uchiyama,Tomohiro Kawamoto,(unknown),(unknown),David J. Hosfield,R.J. Skene,Hua Zou,Jeffrey A. Stafford,Xiaodong Cao,Takashi Ichikawa	13
12	A novel CDC7-selective inhibitor TAK-931 with potent antitumor activity 2016 ·European Journal of Cancer ·(unknown),(unknown),Osamu Kurasawa,Noriko Uchiyama,Akihiro Ohashi	2
13	Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives 2013 ·Journal of Medicinal Chemistry ·Masanori Okaniwa,Masaaki Hirose,Takeo Arita,Masato Yabuki,Akito Nakamura,Terufumi Takagi,Tomohiro Kawamoto,Noriko Uchiyama,(unknown),Shunichirou Tsutsumi,(unknown),Yoshitaka Inui,Bi‐Ching Sang,Jason K. Yano,Kathleen Aertgeerts,Sei Yoshida,Tomoyasu Ishikawa	90
14	TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens 2011 ·Molecular Cancer Therapeutics ·(unknown),Kohei Honda,(unknown),Hitoshi Miyashita,(unknown),Saomi Murai,Noriko Uchiyama,Maki Hasegawa,Tomohiro Kawamoto,Takashi Sato,Takashi Ichikawa,(unknown),Zhe Nie,(unknown),Johnny Yang,Keisuke Kuida,Erik Kupperman	64
15	A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(S )‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease 2011 ·Journal of Neurochemistry ·Tomohiro Onishi,Hiroki Iwashita,Yumiko Uno,Jun Kunitomo,Morihisa Saitoh,Eiji Kimura,Hisashi Fujita,Noriko Uchiyama,Masakuni Kori,Masayuki Takizawa	75
16	Design, synthesis and structure–activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β 2009 ·Bioorganic & Medicinal Chemistry ·Morihisa Saitoh,Jun Kunitomo,Eiji Kimura,Yoji Hayase,Hiromi Kobayashi,Noriko Uchiyama,Tomohiro Kawamoto,Toshimasa Tanaka,Clifford D. Mol,Douglas R. Dougan,(unknown),G. Snell,Fumio Itoh	91
17	Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice 2009 ·Brain Research ·Yumiko Uno,Hiroki Iwashita,Tetsuya Tsukamoto,Noriko Uchiyama,Tomohiro Kawamoto,Masakuni Kori,Atsushi Nakanishi	23
18	2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability 2009 ·Journal of Medicinal Chemistry ·Morihisa Saitoh,Jun Kunitomo,Eiji Kimura,Hiroki Iwashita,Yumiko Uno,Tomohiro Onishi,Noriko Uchiyama,Tomohiro Kawamoto,Toshimasa Tanaka,Clifford D. Mol,Douglas R. Dougan,(unknown),G. Snell,Masayuki Takizawa,Fumio Itoh,Masakuni Kori	101
19	Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment 2002 ·The Journal of Experimental Medicine ·Atsushi Iwama,Mitsujiro Osawa,Ryutaro Hirasawa,Noriko Uchiyama,Shin Kaneko,Masafumi Onodera,Kazuko Shibuya,Akira Shibuya,Charles Vinson,Daniel G. Tenen,Hiromitsu Nakauchi	89
20	Giant Solitary Sebaceous Gland Hyperplasia on the Frontal Region 1990 ·Dermatology ·Noriko Uchiyama,(unknown),Yasuko Shindo	7

About Noriko Uchiyama

Noriko Uchiyama is a scholar working on Organic Chemistry, Cell Biology and Toxicology, having authored 28 papers that have together received 769 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (4 papers), Microtubule and mitosis dynamics (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Molecular Biology (477 citations), Organic Chemistry (183 citations) and Computational Theory and Mathematics (100 citations). Noriko Uchiyama has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tomohiro Kawamoto, Morihisa Saitoh, Eiji Kimura, Jun Kunitomo, Hiroki Iwashita, Masakuni Kori, Yumiko Uno, Douglas R. Dougan, Tomohiro Onishi and Masayuki Takizawa. Their work appears in journals such as The Journal of Experimental Medicine, Brain Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact